# NK Cell-Specific Gata3 Ablation Identifies the Maturation Program Required for Bone Marrow Exit and Control of Proliferation

Alaa Kassim Ali, Jun Seok Oh, Eric Vivier, Meinrad Busslinger, Seung-Hwan Lee

<figure><img src="image_1.png" /></figure>

## To cite this version:

Alaa Kassim Ali, Jun Seok Oh, Eric Vivier, Meinrad Busslinger, Seung-Hwan Lee. NK Cell-Specific Gata3 Ablation Identifies the Maturation Program Required for Bone Marrow Exit and Control of Proliferation. Journal of Immunology, 2016, 196 (4), pp.1753-1767. 10.4049/jimmunol.1501593. hal-01438534

HAL Id: hal-01438534

https://hal.science/hal-01438534

Submitted on 9 Nov 2018

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>
# NK Cell-Specific Gata3 Ablation Identifies the Maturation Program Required for Bone Marrow Exit and Control of Proliferation

Alaa Kassim Ali,* Jun Seok Oh,* Eric Vivier,†,‡ Meinrad Busslinger,§ and Seung-Hwan Lee*

NK cells are innate lymphocytes capable of eliciting an innate immune response to pathogens. NK cells develop and become mature in the bone marrow (BM) before they migrate out to peripheral organs. Although the developmental program leading to mature NK cells has been studied in the context of several transcription factors, the stage-specific role of GATA3 in NK cell development has been incompletely understood. Using *NKp46-Cre-Gata3 flox/flox* mice in which *Gata3* deficiency was induced as early as the immature stage of NK cell differentiation, we demonstrated that GATA3 is required for the NK cell maturation beyond the CD27 single-positive stage and is indispensable for the maintenance of liver-resident NK cells. The frequencies of NK cells from *NKp46-Cre-Gata3 flox/flox* mice were found higher in the BM but lower in peripheral organs compared with control littermates, indicating that GATA3 controls the maturation program required for BM egress. Despite the defect in maturation, upon murine CMV infection, NK cells from *NKp46-Cre-Gata3 flox/flox* mice expanded vigorously, achieving NK cell frequencies surpassing those in controls and therefore provided comparable protection. The heightened proliferation of NK cells from *NKp46-Cre-Gata3 flox/flox* mice was cell intrinsic and associated with enhanced upregulation of CD25 expression. Taken together, our results demonstrate that GATA3 is a critical regulator for NK cell terminal maturation and egress out of the BM and that immature NK cells present in the periphery of *NKp46-Cre-Gata3 flox/flox* mice can rapidly expand and provide a reservoir of NK cells capable of mounting an efficient cytotoxic response upon virus infection.

Natural killer cells are an important component of the innate immune system. They have gained much attention because of their ability to kill transformed cells without prior sensitization to Ag (1, 2). NK cells can induce the activation of other immune cells by producing proinflammatory cytokines such as IFN-γ and TNF-α (3). In addition, NK cells mediate the direct killing of target cells by secreting cytotoxic granules that contain perforin and granzymes (4, 5). Because NK cells play a

major role in the early control of viral infection and cancer, understanding the molecular mechanism by which NK cells fully develop and become functionally mature is of great importance. NK cells primarily undergo the development and maturation program in the bone marrow (BM). When they become mature, NK cells migrate through the bloodstream and seed into peripheral organs such as the spleen, liver, and lungs, where they can provide early protection against infection (6, 7). In the BM, NK precursor cells (NKPs) express the IL-2R β-chain (CD122), and this receptor is maintained in all of the stages of NK cell development. CD122 in combination with the common γ-chain (CD132) form the IL-2/15R, allowing NK cells to be responsive to IL-15. NK cell development depends on IL-15 and the downstream signaling molecules JAK1/3 and STAT5 (8–10). Immature NK (iNK) cells can be identified by the expression of NK1.1, and these cells further develop into mature NK (mNK) cells as they acquire CD11b. Notably, NK cells in the BM differentiate through four stages of maturation, which are associated with the acquisition of the surface markers CD27 and CD11b (11, 12). In the first stage, NK cells lack both CD27 and CD11b receptors. In the second and third stages, NK cells acquire CD27 and CD11b respectively. In the last stage of maturation, NK cells become negative for the expression of CD27. Therefore, NK cells develop as follows: $CD27^-$CD11b$^-$, $CD27^+$CD11b$^-$, $CD27^+$CD11b$^+$, and $CD27^-$CD11b$^+$.

Numerous elegant studies using immune cell-specific deficient mice or in vitro NK cell differentiation have defined factors responsible for the developmental process of NK cells (7, 13, 14). Examples of those transcription factors include Id2, E4bp4 (also known as Nfil3), T-bet, and Eomes. Id2 is an antagonist of the transcription factor TCF3, which promotes the development of B cells and myeloid cells (15). Eomes was known to bind the CD122 promoter region and significantly lower CD122 expression, and reduced responsiveness to IL-15 was observed in NK

<footnote>*Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada; †Centre d'Immunologie de Marseille-Luminy, Aix-Marseille Université UM2, INSERM, U1104, CNRS UMR7280, 13288 Marseille, France; ‡Immunologie, Hôpital de la Conception, Assistance Publique-Hôpitaux de Marseille, 13385 Marseille, France; and §Research Institute of Molecular Pathology, Vienna Biocenter, Vienna 1030, Austria</footnote>

<footnote>Received for publication July 15, 2015. Accepted for publication December 7, 2015.</footnote>

<footnote>This work was supported by funding from the J.P. Bickell Foundation and the Canadian Institutes of Health Research (to S.-H.L.). S.-H.L. holds a Canada Research Chair in Viral Infection and Immunity. E.V.'s laboratory is supported by the European Research Council (THINK Advanced Grant), the Ligue Nationale contre le Cancer (Equipe Labellisée), Sanofi, and by institutional grants from INSERM, CNRS, and Aix-Marseille Université to Centre d'Immunologie de Marseille-Luminy. E.V. is a scholar of the Institut Universitaire de France. M.B. was supported by Boehringer-Ingelheim and the European Research Council (Advanced Grant 291740-LymphoControl).</footnote>

<footnote>Address correspondence and reprint requests to Dr. Seung-Hwan Lee, Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada. E-mail address: seunglee@uottawa.ca</footnote>

<footnote>The online version of this article contains supplemental material.</footnote>

<footnote>Abbreviations used in this article: BM, bone marrow; cNK, conventional NK; DN, double-negative; DP, double-positive; F, forward; iNK, immature NK; KLRG1, killer cell lectin-like receptor subfamily G, member 1; MCMV, murine CMV; mNK, mature NK; NKP, NK precursor cell; PDPK1, 3-phosphoinositide-dependent protein kinase-1; R, reverse; rh, recombinant human; rm, recombinant murine; RP-10, RPMI 1640, 10% FBS, 1× penicillin/streptomycin, 1% L-glutamine, 10 mmol HEPES, 50 µmol 2-ME; S1P5, sphingosine-1-phosphate receptor 5; SP, single-positive.</footnote>
cells from Eomes-deficient mice (16). E4bp4 seems to function
upstream of Eomes, so that E4bp4 deficiency caused severe de-
fects in NK cell development (17, 18). A recent paper demon-
strated that NK cells deficient in 3-phosphoinositide-dependent
protein kinase-1 (PDPK1), a kinase downstream of PI3K and
upstream of mammalian target of rapamycin, are unable to dif-
ferentiate into NK cells in vivo (19). Rescue of the defect of
PDPK1 by ectopic expression of E4bp4 or Eomes suggests that
PDPK1 signaling is critical for NK cell development via induction
of E4bp4 and Eomes. Lastly, NK cell development is altered in the
absence of T-bet, resulting in increased numbers of NK cells in the
BM and reduced peripheral NK cell numbers. T-bet and Eomes
seem to play roles in regulating CD122 in NK cells (16, 20).

Several tissue-specific NK cell subsets have been identified, and
their origins and differentiation programs are current topics of
interest. Not only critical for T cell development, the thymus also
generates a unique NK cell population called thymic NK cells. In
contrast to the dispensable role of IL-7 for conventional NK (cNK)
cells, thymic NK cells express IL-7Rα and are highly dependent
on IL-7 (21). More recently, liver-resident NK cells defined as
CD49b⁻ and CD49a⁺ were identified. They appeared phenotypi-
cally immature by expressing TRAIL (22), but showed relatively
low proliferative capacity at the steady state (23). Adoptive
transfer of hepatic mononuclear cells rescued the liver-resident
NK cell population in lethally irradiated recipient mice, demon-
strating that liver-specific hematopoietic progenitor cells are the
origin of hepatic CD49b⁻CD49a⁺ NK cells (24). The liver-
resident NK cells produce large amounts of TNF-α and IL-2
and less IFN-γ, suggesting their unique function (25). Notably,
these cells have been demonstrated to exhibit memory potential in
a model of hapten-specific contact hypersensitivity (24). Further-
more, a recent study of transcriptomic analysis indicated that cNK
cells, thymic NK cells, and liver-resident NK cells are all gener-
ated as distinct lineages (25).

From a family of six transcription factors termed GATA bind-
ing protein, GATA3 contains two zinc-finger motifs that bind the
consensus sequence [A/T]GATA[A/G] promoter elements (26).
GATA3 is known to play crucial roles in a variety of immune cells
in a developmental stage- and cell-lineage-specific fashion (27).
For instance, GATA3 is important in the development and main-
tenance of T cells (27-29). Notably, GATA3 plays a critical role in
the differentiation of Th2 cells and their ability to secrete cyto-
kines such as IL-4, IL-5, and IL-13. GATA3 is also expressed in
the NK cell lineage, and its role is restricted to the NK cell
maturation, as GATA3 deficiency did not result in a major defect
in NK cell frequencies but led to reduced T-bet expression
accompanied by defective IFN-γ production and liver-specific
homing of NK cells (30). Similar to T cells' developmental re-
quirement for GATA3, thymic NK cells expressing IL-7Rα re-
quire GATA3 (21) and are absent in *Vav-Cre-Gata3<sup>fl/fl</sup>* mice (25).
However, cNK cells and liver-resident NK cells are still present in
the *Vav-Cre-Gata3<sup>fl/fl</sup>* mice (25, 31) in which *Gata3* deficiency is
induced in all hematopoietic cells at the early stage of develop-
ment, indicating the dispensable role of GATA3 in their early
development. Therefore, the lineage- and stage-specific roles of
GATA3 during NK cell development without the influence from
other cell types are warranted. In this study, we generated a
conditional *Gata3*-deficient mouse using NKp46-Cre mice to
dissect the role of *Gata3* at the late stage of NK cell development.
We demonstrate that GATA3 is required for NK cell maturation
beyond the acquisition of CD27. The incomplete maturation of
NK cells due to GATA3 deficiency resulted in a defect in BM
egress, and this was associated with decreased NK cell frequen-
cies in peripheral organs. Surprisingly, despite the intrinsic defect

in NK cell maturation and accompanying decrease of NK cell
frequencies in the periphery, comparable protection between NK
cell-specific *Gata3* knockout mice and control littermates was
observed during murine CMV (MCMV) infection. This protection
was due to enhanced expansion of NK cells in the periphery of
*NKp46-Cre-Gata3*<sup>fl/fl</sup> mice and associated with enhanced upregu-
lation of CD25 expression. Therefore, our result suggests that iNK
cells found in peripheral organs can proliferate vigorously and
spread and could provide a reservoir of efficient effector NK cells
during a virus infection.

**Materials and Methods**

Mice and genotyping

NKp46<sup>Cre</sup> knockin (32), *Gata3*<sup>flox</sup> mice (33, 34), and CD45.1<sup>+</sup> Ly49H<sup>-/-</sup>
mice (35) were housed in a specific pathogen-free environment. The
*Ly49h*-intron primers were D6Ott151-forward (F): 5'-GTGCTACCACT-
GAAAACCATGG-3' and D6Ott151-reverse (R): 5'-CTGTCTCTTGAGT-
CACCTGCAC-3' (36). The *Gata3* floxed and *Gata3* deleted alleles
were genotyped using the following primers: F, 5'-GTCAGGGCAC-
TAAGGGTTGTT-3'; floxed-R, 5'-TGGTAGAGTCCGCAGGCATTG-3';
and deleted-R, 5'-TATCAGCGGTTCATCTACAGC-3' (33). To identify
the specificity of *Gata3* deletion by Cre recombinase, T cells, B cells, and
NK cells from spleen and NKT cells from liver of *NKp46-Cre-Gata3*<sup>fl/fl</sup>
mice were isolated and sorted using littermate controls from the *NKp46-
Cre<sup>+/-</sup> × *Gata3flox<sup>+/+</sup> × NKp46-Cre<sup>-/-</sup> × *Gata3flox<sup>+/+</sup>* mating. All mice
used for experiments were between 6 and 12 wk old. All procedures were
approved by and conducted in accordance with the institution's animal
guidelines of the University of Ottawa.

Cell isolation

Spleen and blood were harvested, and a single-cell suspension was obtained following RBC lysis and filtration through a 70-µm filter. Leukocytes were isolated from liver using Percoll gradient centrifugation. BM cells were extracted from tibia and femur.

Abs and flow cytometry

The following mAbs were used: anti-GATA3 (TWAJ), anti-NK1.1 (PK136), anti-CD3 (17A2 and 145-2C11), anti-CD27 (LG.7F9), anti-CD11b (M1/70), anti-Ly49D (4E5), anti-Ly49G2 (4D11), anti-Ly49H (3D10), anti-NKG2D (CX5), anti-NKG2A-B6 (16a11), anti-CD62L (MEL-14), anti-killer cell lectin-like receptor subfamily G, member 1 (KLRG1; 2F1), anti-TCRβ (H57-597), anti-CXCR4 (2B11), anti-IFN-γ (XMG1.2), anti-CD45.2 (104), anti-CD25 (PC61.5), anti-CD49b (DX5), and anti-CD107a (1D4B) from eBioscience; anti-GATA3 (L50-823), anti-Ly49C/I (5E6), anti-CXCR3 (CXCR3-173), anti-STAT4 (8/Stat4), anti-IgG1 (A85-1), anti-p-STAT4 (38/p-Stat4), anti-CD49a (Ha31/8), anti-CD19 (1D3), anti-Ki-67 (B56), and anti-BrdU (3D4) from BD Biosciences; anti-IL-12Rβ2 (305719) and anti-IL-18Rα (112614) from R&D Systems; mouse IgG1, κ (MOPC-21) and rat IgG2b, κ (RTK4530) from BioLegend; and Fixable Far Red Live/Dead from Invitrogen. For intracellular IFN-γ measurements in vivo, leukocytes from BM, spleen, and liver were harvested postinfection at day 1.5 and incubated in RPMI 1640, 10% FBS, 1× penicillin/streptomycin, 1% L-glutamine, 10 mmol HEPES, 50 µmol 2-ME (RP-10) media containing 5 µg/ml brefeldin A for 4 h, followed by staining for intracellular IFN-γ using BD Cytofix/Cytoperm protocols (BD Biosciences). Intracellular staining of GATA3 and Ki-67 was carried out using a Foxp3 staining kit (eBioscience). Surface staining of CXCR4 was performed at 37°C for 10 min. Cells were acquired using FACS Cyan ADP and analyzed using Kaluza software v2 (Beckman Coulter) and FlowJo (Tree Star).

Induced egress of NK cells from BM to the blood

NK cell exit from BM and labeling of sinusoidal lymphocytes were achieved as described previously (37). Briefly, AMD3100 (Sigma-Aldrich) was given i.p. (150 µg/mouse) 1 h before sacrifice. To label sinusoidal lymphocytes, mice were injected i.v. with 1 µg anti-CD45.2 mAb conjugated with biotin (eBioscience). Mice were sacrificed 2 min after Ab injection. Then, cells were isolated from the blood and BM and stained with Streptavidin-PE before being analyzed using FACS Cyan ADP and Kaluza software v2 (Beckman Coulter).
### Transwell migration assay

Transwell assay was performed as previously described (37, 38). Briefly, 5-µm pore transwell inserts were used to analyze the migratory response of BM cells to CXCL12. BM cells were pretreated with or without 50 µmol AMD3100 for 90 min in RPMI 1640 medium supplemented with 1% FBS. Cells were then washed and counted. Using the same media, 50 ng/ml CXCL12 was prepared, and 500 µl/well was added into a Transwell-24 well plate (Corning). The inserts were placed inside the wells, and 5 × 10⁵ cells was loaded into each insert. After incubating the plate at 37°C for 3 h, the migrated cells were collected. The cells were counted, and the frequency of NK cells was determined by flow cytometry. Cell migration was calculated as percentage of input NK cells.

### IFN-γ production upon in vitro stimulation

Spleens were harvested, and a single-cell suspension of splenic leukocytes was enriched by negative selection using the EasySep Mouse NK cell enrichment kit (Stemcell Technologies). Cells were then seeded in triplicates in RP-10 media on Ab-coated plates or cultured with different combinations of recombinant human (rh)IL-2 (1000 U/ml; National Institutes of Health/National Cancer Institute at Frederick Biological Resources Branch Preclinical Repository), recombinant murine (rm)IL-12 (50 ng/ml; eBioscience), and rmIL-18 (100 ng/ml; PeproTech). After 1 h of stimulation, brefeldin A was added to a final concentration of 5 µg/ml, and cells were incubated for 4 h followed by staining for intracellular IFN-γ using BD Cytofix/Cytoperm protocols (BD Biosciences).

### MCMV infection, cytokine quantification, and viral titration

Smith strain MCMV stocks were generated in our laboratory from infected salivary glands of BALB/c mice and viral titers determined by standard plaque assays (36). Mice were infected with 5000 PFUs MCMV i.p. To measure viral burdens in organs, spleens and livers from infected mice were homogenized by MagNA Lyser (Roche Applied Science), and the lysates were appropriately diluted and overlaid on mouse embryonic fibroblast cells in duplicates in 2% DMEM (2% FBS, 1× penicillin/streptomycin, 1% L-glutamine, and 10 mmol HEPES). Plaques were counted 3 d later and represented as log PFU per gram organ. Blood serum from naive or infected mice were appropriately diluted and analyzed for the production of mouse IFN-γ and IL-12 using a Cytometric Bead Array kit (BD Biosciences). Samples were prepared according to the manufacturer's instructions, acquired on FACS Cyan ADP (Beckman Coulter), and analyzed using the BD FCAP Array Software (BD Biosciences).

### NK cell cytotoxicity assay

NK cell cytotoxicity was measured by analyzing the antitumor activity of NK cells against YAC-1 target cells. Splenic leukocytes were isolated from *Gata3fl/fl* or *NKp46-Cre-Gata3fl/fl* mice that were either naive or infected with MCMV. To ensure equal numbers of NK cells were used, spleen populations were surface stained for NK and T cells and each sample adjusted to appropriate concentrations in sterile NK media (RPMI 1640, 10% FBS, 1× penicillin/streptomycin, 1% L-glutamine, 10 mmol HEPES, 50 µmol 2-ME, 1% nonessential amino acids, and 1 mmol sodium pyruvate). YAC-1 cells were cultured in sterile RP-10 media and labeled with 100 µCi [51Cr] for 1 h at 37°C, washed three times with PBS, and made to a concentration of 5 × 10⁴ cells/ml in NK medium. In V-bottom 96-well plates, 100 µl YAC-1 cells were added in triplicates and incubated for 4 h with 100 µl effector cells with E:T ratios ranging from 0.3:1 to 10:1. Supernatants were then used to quantify the amount of [51Cr] released due to specific lysis of YAC-1 targets by NK cells, and counted using a 2470 WIZARD² Automatic γ Counter (PerkinElmer). NK cytotoxicity was calculated according to the formula: % specific [51Cr] release = ([experimental release - minimum release]/[maximum release - minimum release]) × 100.

### In vitro assay for NK cell proliferation

Spleens were harvested under sterile conditions, and a single-cell suspension of splenic leukocytes was generated after RBC lysis and filtration through 70-µm nylon mesh. Cells were enriched by negative selection using the EasySep Mouse NK cell enrichment kit (Stemcell Technologies) and labeled with Cell Proliferation Dye eFluor 450 (eBioscience). Cells were then cultured in 96-well plates in triplicates in RP-10 media with different concentrations of rhIL-2 or rmIL-15 (eBioscience). To measure BrdU incorporation, BrdU was added to the culture at a final concentration of 10 µmol, 24 h before harvesting the cells.

### CD25 induction and STAT4 phosphorylation

To evaluate CD25 induction on NK cells, 5E5 total splenocytes were stimulated in a 96-well plate with rmIL-12 (10 ng/ml; eBioscience) and/or

rmIL-18 (10 ng/ml; PeproTech) for 24 h. To measure total STAT4 levels, cells were first stained using purified anti-STAT4 Ab followed by a secondary staining using anti-IgG1 conjugated to PE. To detect p-STAT4, cells were rested at 37°C for 4 h. Cells were then stimulated with rmIL-12 (10 ng/ml) and rmIL-18 (50 ng/ml) for 30 min before staining. To measure STAT4 and p-STAT4, cells were fixed with BioLegend Fix/Perm buffer and permeabilized with prechilled 100% methanol before intracellular staining.

### Adoptive transfer

Spleen cells from *Gata3fl/fl* or *NKp46-Cre-Gata3fl/fl* mice (CD45.2⁺) were isolated, and equal numbers of Ly49H⁺ NK cells were transferred into

<figure><img src="image_3.png" /></figure>

**FIGURE 1.** Deletion of the *Gata3* gene (exon 4) occurs predominantly in NK cells. Genomic deletion of *Gata3* and protein expression of GATA3 in *NKp46-Cre-Gata3fl/fl* mice and control littermates. (A) In *Gata3fl/fl* mice, exon 4 of *Gata3* gene is flanked with *loxP* sites. Crossing *Gata3flox* mice with *NKp46-Cre* mice leads to Cre-mediated recombination, resulting in exon 4 deletion. Diagram is not to scale. (B) Sorted T, B, NK, and NKT cells were genotyped to determine the presence of *Gata3*-floxed allele and *Gata3*-deleted allele. Semiquantitative genomic PCR was performed on serial 5-fold dilutions of DNA from the different cell populations. (C) GATA3 protein level was measured by flow cytometry in splenic NK cells (NK1.1⁺CD3⁻), T cells (NK1.1⁻CD3⁺), and non-NK/non-T cells (NK1.1⁻CD3⁻) from *NKp46-Cre-Gata3fl/fl* and *Gata3fl/fl* mice. (D) GATA3 protein level was measured by flow cytometry in BM NKPs (CD3⁻CD122⁺NK1.1⁻CD11b⁻), iNK (CD3⁻CD122⁺NK1.1⁺CD11b⁻), and mNK cells (CD3⁻CD122⁺NK1.1⁺CD11b⁺) from *NKp46-Cre-Gata3fl/fl* and *Gata3fl/fl* mice. Data are from one experiment representative of at least two independent experiments.
Ly49H<sup>-/-</sup> recipients (CD45.1<sup>+</sup>). Ly49H<sup>-/-</sup> recipients were either uninfected or given 3000 PFU MCMV i.p. 1 d following adoptive transfer. Leukocytes from spleen and liver of recipient mice were harvested on day 5 postinfection.

## Quantitative real-time PCR

NK cells from *Gata3<sup>fl/fl</sup>* or *Nkp46-Cre-Gata3<sup>fl/fl</sup>* mice were enriched by negative selection using the EasySep Mouse NK cell enrichment kit (Stemcell Technologies) and sorted using MoFlo Astrios (Beckman Coulter). Purities of sorted NK cells were >98%. Total RNA was extracted from the sorted NK cells using TRIzol reagent (Life Technologies) according to the manufacturer's instructions. Using 35 ng total RNA, cDNA was reverse transcribed in a 20-µl reaction using the First Strand cDNA Synthesis kit (Thermo Scientific). For quantification of Gapdh and target genes by real-time PCR, cDNA was added to a 20-µl reaction of FastStart Universal SYBR Green Master (Rox) (Roche) and amplified using ViiA 7 Dx Real-Time PCR Instrument (Applied Biosystems). Expression of target genes was normalized to Gapdh levels. The primer sequences for Gapdh are: F, 5'-ACCA-CAGTCCATGCCATCAC-3' and R, 5'-TCCACCACCCTGTTGCTGTA-3'; for Id2 are F, 5'-ATGAAAGCCTTCAGTCCGGTG-3' and R, 5'-AGC-AGACTCATCGGGTCGT-3'; for T-bet are F, 5'-CTAAGCAAGGACG-GCGAATGT-3' and R, 5'-GGCTGGGAACAGGATACTGG-3'; for E4bp4 are F, 5'-GAACTCTGCCTTAGCTGAGGT-3' and R, 5'-ATTCCCGTTT-TCTCCGACACG-3'; for Ets1 are F, 5'-TGAATGTGCAGATGTCCCG-3' and R, 5'-TGAGCATGCTCGATACCGTA-3'; for Irf2 are F, 5'-CGAT-

TATTCAACTGACGGGCTTTC-3' and R, 5'-GCATTCGCATCCGTT-CCAC-3'; for Eomes are F, 5'-GATGTACGTTCACCCAGAAT-3' and R, 5'-ATCGTAGTTGTCCCGGAAGC-3'; and for Tox are F, 5'-CTA-CTGCAGTAGTCGGTACTCC-3' and R, 5'-CTGAAGCAGCTAGCAG-CATAC-3'.

## Statistical analysis

Significance of results was determined by two-tailed unpaired Student *t* tests (\*p < 0.05, \*\*p < 0.01, \*\*\*p < 0.001) and graphed using Prism Version 5 (GraphPad Software).

## Results

### Generation of *Nkp46-Cre-Gata3<sup>fl/fl</sup>* mice

The complete ablation of *Gata3* leads to embryonic lethality due to noradrenaline deficiency and improper kidney development (33, 39). Developmental stage-specific roles of *GATA3* in diverse immune cells have been demonstrated (27). To investigate the role of *GATA3* at the late stage of development of NK cells, we generated *Nkp46-Cre-Gata3<sup>fl/fl</sup>* mice using a mouse expressing the Cre recombinase under the *Nkp46* promoter. Compared to *Vav-Cre-Gata3<sup>fl/fl</sup>* mice, *Nkp46-Cre* expression is induced at a stage of NK cell development that follows the acquisition of NK1.1,

<figure><img src="image_4.png" /></figure>

<figure><img src="image_5.png" /></figure>

<figure><img src="image_6.png" /></figure>

<figure><img src="image_7.png" /></figure>

**FIGURE 2.** NK cell frequencies and maturation are perturbed in the absence of *GATA3*. Flow cytometric analysis of NK cell populations in the BM, spleens, and livers of *Nkp46-Cre-Gata3<sup>fl/fl</sup>* and *Gata3<sup>fl/fl</sup>* mice. (A) Representative plots of NK cell (NK1.1<sup>+</sup>CD3<sup>-</sup>) frequencies. (B) Percentage and number of NK cells (NK1.1<sup>+</sup>CD3<sup>-</sup> or NK1.1<sup>+</sup>TCR-β<sup>-</sup>) in *Gata3<sup>fl/fl</sup>* (white bars) or *Nkp46-Cre-Gata3<sup>fl/fl</sup>* (black bars) mice. (C) Representative plots of CD27<sup>-</sup>CD11b<sup>-</sup> (DN), CD27<sup>+</sup>CD11b<sup>-</sup> (CD27 SP), CD27<sup>+</sup>CD11b<sup>+</sup> (DP), and CD27<sup>-</sup>CD11b<sup>+</sup> (CD11b SP) populations among NK cells (NK1.1<sup>+</sup>CD3<sup>-</sup>). (D) Percentages of DN, CD27 SP, DP, and CD11b SP populations in *Gata3<sup>fl/fl</sup>* (white bars) or *Nkp46-Cre-Gata3<sup>fl/fl</sup>* (black bars) mice. For (A) and (D), data were pooled from at least two independent experiments, with five to nine mice per group. For (C) and (D), data are from one experiment representative of at least two independent experiments, with three mice per group. Data represent mean ± SD. \*p < 0.05, \*\*p < 0.01, \*\*\*p < 0.001.
therefore allowing us to study the role of GATA3 at a late stage of
development. In a previous report, Gata3<sup>fl/fl</sup> mice that carry loxP
sites flanking exon 4 of the Gata3 locus have been successfully
used to generate conditional Gata3-deficient mice (Fig. 1A) (33,
40). To determine whether Cre-mediated recombination occurred
only in cNK cells in the spleens of NKp46-Cre-Gata3<sup>fl/fl</sup> mice, we
extracted genomic DNA from sorted T, B, NK, and NKT cells
isolated from NKp46-Cre-Gata3<sup>fl/fl</sup> mice and determined the Cre-
mediated recombination by genomic DNA PCR. The Gata3-
floxed allele was present among sorted T cells, B cells, and
NKT cells but only weakly amplified from sorted NK cells
(Fig. 1B). Contrarily, the Gata3-deleted allele was predominately
detected from sorted NK cells but not in other populations. Intron
1 of Ly49h gene was used as control and showed similar genomic
abundance between the different sorted populations. These results
indicate that the genomic deletion of Gata3-exon 4 occurred
predominantly in splenic NK cells of NKp46-Cre-Gata3<sup>fl/fl</sup> mice.

We also evaluated GATA3 protein expression in NK cells from NKp46-Cre-Gata3<sup>fl/fl</sup> mice and their control littermates that carry loxP-flanked Gata3 alleles but lack NKp46-Cre (Gata3<sup>fl/fl</sup> mice). GATA3 is known to be expressed in mature T cells but not in B cells or myeloid cells (40). Accordingly, T cells expressed high levels of GATA3, and this expression was at a similar intensity as NK cells from control mice (Fig. 1C). Non-T/non-NK cells that are composed of B cells and myeloid cells did not express GATA3 as expected. Notably, NK cells from NKp46-Cre-Gata3<sup>fl/fl</sup> showed reduced expression of GATA3 compared with NK cells from control mice. To determine at which stage of NK cell differentiation GATA3 expression is abrogated in Gata3<sup>fl/fl</sup> mice, we measured the expression of GATA3 in NKPs, iNK cells, and mNK cells in the BM. GATA3 was not expressed in NKPs, but was induced at the iNK stage and retained its expression in mNK cells (Fig. 1D). However, in NKp46-Cre-Gata3<sup>fl/fl</sup> mice, GATA3 expression was reduced in both iNK and mNK cells, suggesting that NKp46-Cre-induced Gata3 downmodulation occurs as early as the iNK cell stage. Taken together, the NKp46-Cre-Gata3<sup>fl/fl</sup> mouse is an adequate model to study the role of GATA3 in the development and maturation of NK cells.

GATA3 is required for NK cell maturation and exit
from the BM

Previously, GATA3 deficiency at the hematopoietic stem cell stage was shown to promote the homing of NK cells into the liver (30). To determine whether GATA3 influences the distribution of NK cells within different compartments, we examined the NK cell frequencies in the BM, spleen, and liver of NKp46-Cre-Gata3<sup>fl/fl</sup> mice. Compared to their control littermates, NK cell frequencies and numbers in NKp46-Cre-Gata3<sup>fl/fl</sup> mice were found higher in the BM but lower in the spleen and liver (Fig. 2A, 2B), suggesting a defect in the egress of NK cells from the BM to peripheral organs in the absence of GATA3.

To investigate the role of *Gata3* in the NK cell maturation process, we assessed the maturation of NK cells in *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice. NK cells from *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice displayed an immature phenotype, and this was characterized by an increase in double-negative (DN) and CD27 single-positive (SP) populations and a decrease in double-positive (DP) and CD11b SP subsets. This was shown in all three organs tested (Fig. 2C, 2D). Therefore, GATA3 is important for the differentiation of NK cells from CD27 SP to DP.

GATA3 is required for the development of CD49a<sup>+</sup>
liver-resident NK cells

The newly identified CD49b<sup>-</sup>CD49a<sup>+</sup> liver-resident NK cells
are known to be generated from hepatic hematopoietic pro-

genitors (24). Because a defect in the homing of NK cells into
the liver has been identified in chimeric mice using Gata3-de-
ficient fetal liver cells (30), the dramatic reduction of NK cells
in the livers shown in the previous report might not be due to the
lack of hepatic progenitor cells. Alternatively, GATA3 is re-
quired for the development of liver-resident NK cells from he-
patic progenitor cells. To test this possibility, both cNK cells
and liver-resident NK cells, which express CD49b and CD49a,
respectively, were analyzed in NKp46-Cre-Gata3<sup>fl/fl</sup> mice. A
reduction in the numbers of cNK cells was found in NKp46-Cre-
Gata3<sup>fl/fl</sup> mice, which can be explained by the inability of these
cells to home into the liver (Fig. 3A, 3B). Interestingly, the
numbers of liver-resident NK cells were also reduced in NKp46-
Cre-Gata3<sup>fl/fl</sup> mice, indicating that GATA3 is required for the

<figure><img src="image_8.png" /><figcaption>FIGURE 3. Numbers of liver-resident NK cells are reduced in NKp46-Cre-Gata3<sup>fl/fl</sup> mice. (A) Representative plots of liver-resident NK cells (NK1.1<sup>+</sup>CD3<sup>-</sup>CD49b<sup>-</sup>CD49a<sup>+</sup>) at the steady state. (B) Percentages and numbers of cNK or liver-resident NK cells in Gata3<sup>fl/fl</sup> (white bars) or NKp46-Cre-Gata3<sup>fl/fl</sup> (black bars) mice. For (A), data are from one experiment representative of two independent experiments. For (B), data were pooled from two independent experiments, with six to seven mice per group. Data represent mean + SD. **p < 0.01, ***p < 0.001.</figcaption></figure>
development of liver-resident NK cells. The impaired ability of cNK cells to migrate from the BM to the liver in combination with the defective development of liver-resident NK cells in the

absence of GATA3 is consistent with the dramatic reduction of NK1.1⁺CD3⁻ cell frequencies in the livers of *NKp46-Cre-Gata3 flox/flox* mice (Fig. 2A, 2B).

<figure><img src="image_9.png" /></figure>

<figure><img src="image_10.png" /></figure>

<figure><img src="image_11.png" /><figcaption>**FIGURE 4.** Surface expression of several activating and inhibitory receptors and molecules involved in cell adhesion is reduced on NK cells from *NKp46-Cre-Gata3 flox/flox* mice. Flow cytometric analysis of several activating and inhibitory receptors and adhesion molecules on NK cells from *NKp46-Cre-Gata3 flox/flox* and *Gata3 flox/flox* mice. (A) Representative plots of surface receptors in BM, spleens, and livers of *NKp46-Cre-Gata3 flox/flox* or *Gata3 flox/flox* mice. (B and C) Percentage of NK cells (NK1.1⁺CD3⁻ or NK1.1⁺TCR-β⁻) expressing the indicated receptors in *Gata3 flox/flox* (white bars) or *NKp46-Cre-Gata3 flox/flox* (black bars) mice. Data were pooled from at least two independent experiments, with 5–12 mice per group. Data represent mean ± SD. \*p < 0.05, \*\*p < 0.01, \*\*\*p < 0.001.</figcaption></figure>
GATA3 modulates the expression of transcription factors involved in NK cell development

The critical roles of GATA3 in the development of diverse immune cells suggest that GATA3 might function indirectly by positively or negatively modulating other transcription factors. To gain insight into the mechanism underlying the GATA3-governed regulation of transcription factors, we measured the mRNA level of transcription factors known to drive NK cell development. Gata3-deficient NK cells showed reduced expression of *Id2*, *T-bet*, and *E4bp4* (Supplemental Fig. 1A). Downmodulation of these transcription factors could be in line with developmental defects observed in *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice. Notably, defects in NK cell maturation in *Id2*-deficient or *E4bp4*-deficient NK cell progenitor cells are the most severe and result in a maturation blockade occurring before NK1.1 acquisition in the BM (17, 41, 42), different from the accumulation of NK1.1<sup>+</sup> iNK cells in *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice, suggesting GATA3 involvement in multiple stages of NK cell development. The NK cell developmental defect in *T-bet*-deficient mice showed increased numbers of NK cells in the BM and reduced peripheral NK cell numbers, similar to *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice (43). Paradoxically, mRNA expression of *Tox*, which is required for NK cell maturation, was found abundant in NK cells from *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice (44). Taken together, this result suggests a complex interplay between GATA3 and these transcription factors during the development of NK cells.

The expression of molecules involved in cell adhesion is dictated by GATA3 on NK cells

To understand GATA3-mediated control in NK cell development, we decided to further characterize the expression of several surface receptors on NK cells from *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice and their control littermates. In *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice, the expression of inhibitory and activating receptors was slightly reduced in the spleen and liver (Fig. 4A, 4B). Surprisingly, *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice exerted dramatically perturbed expression of molecules involved in cell adhesion such as CD11b and CD62L on NK cells (Fig. 4A, 4C).

Known to associate with CD18 to form an integrin (45), CD11b was poorly expressed on NK cells in all three compartments analyzed from *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice. The proportion of NK cells expressing L-selectin (CD62L) was also decreased in these mice. Interestingly, NK cells from *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice showed increased expression of the chemokine receptor CXCR3. Although the role of CXCR3 on NK cell migration at the steady state is unclear, it has been shown to be important for the recruitment of NK cells into tumors (46). Thus, the altered expression of molecules involved in cell adhesion may explain the defective ability of NK cells to exit the BM in *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice.

Because CD27<sup>+</sup>CD11b<sup>-</sup> iNK cells are overrepresented in total NK cells, we decided to compare the phenotypes in subsets of distinct maturation stages based on the expression of CD27 and CD11b. The expression pattern of most surface receptors was similar in NK cell subsets of equivalent maturation stages when comparing *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice with their control littermates (Supplemental Fig. 1B, 1C), indicating that the differential expression can be explained by higher proportions of CD27<sup>+</sup>CD11b<sup>-</sup> iNK cells in *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice. In addition, the expression of the inhibitory receptor KLRG1 was almost completely abrogated on NK cells from *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice (Fig. 4A, 4C). However, the expression of KLRG1 was drastically different in DP and CD11b SP subsets, suggesting that KLRG1 expression is directly GATA3 regulated.

GATA3-deficient NK cells localized in the BM can be mobilized to the blood following treatment with CXCR4 antagonist

Among various chemokine receptors, the critical role of CXCR4 on the retention of NK cells in the BM was suggested (37). The expression of CXCR4 is decreased in mature NK cells, making these cells less responsive to CXCL12, a CXCR4 ligand highly expressed in the BM environment (37, 47–49). Injection of mice

<figure><img src="image_12.png" /><figcaption>**FIGURE 5.** NK cells from *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice can be recruited to the blood upon blockade of CXCR4. Flow cytometric analysis of BM and blood NK cells in *NKp46-Cre-Gata3*<sup>fl/fl</sup> or *Gata3*<sup>fl/fl</sup> mice treated for 1 h with PBS (control) or AMD3100 and injected i.v. with biotin-conjugated anti-CD45 mAb for the final 2 min. (A) Representative plot of NK cell frequencies among CD45<sup>+</sup> cells in the BM. (B) Percentage of NK cells among CD45<sup>+</sup> cells in the BM. (C) Number of sinusoidal NK cells (CD45<sup>+</sup> NK cells) in the BM. (D) Number of NK cells in the peripheral blood of PBS-treated (white bars) or AMD3100-treated (black bars) mice were measured. (E) Representative plots of CD27 and CD11b expression in gated CD45<sup>+</sup> (sinusoidal) NK cells from BM. (F) NK cell migration in response to CXCL12 was assessed following BM pretreatment with or without AMD3100. (G and H) Mean fluorescence intensity (MFI) of CXCR4 expression of BM NK cells. For (A)–(D), data were pooled from three independent experiments, with two to three mice per group. For (F), data are from one experiment representative of two independent experiments, with four replicates per group. For (G) and (H), data are from one experiment representative of two independent experiments, with three mice per group. Data represent mean ± SD. \*p < 0.05, \*\*p < 0.01.</figcaption></figure>
with the CXCR4 antagonist AMD3100 resulted in the recruitment of iNK cells from the BM to the blood (37). Given that NK cells from *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice are immature and that these NK cells show a defect in egress from the BM to the periphery, we sought to determine whether the use of AMD3100 would allow NK cells to exit the BM in *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice. Mice were injected i.p. with AMD3100 for 1 h and then injected i.v. with anti-CD45.2 mAb 2 min before sacrifice to label sinusoidal lymphocytes. PBMCs and BM were analyzed. In control littermates, the proportion of NK cells in BM sinusoids was not altered following injection of AMD3100 (Fig. 5A, 5B). However, NK cell frequencies within BM sinusoids were increased in AMD3100-treated *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice. Similarly, the fold change of the absolute NK cell number in BM sinusoids upon AMD3100 treatment was heightened in *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice (Fig. 5C). This was associated with increased number of NK cells in the blood (Fig. 5D), even though the effect was not as dramatic as in BM sinusoids. As shown previously (37), the immature CD27 SP NK cells were selectively recruited to the BM sinusoids and the blood upon CXCR4 antagonist AMD3100 treatment (Fig. 5E), suggesting that antagonizing CXCR4 rescues the defective egress of immature *Gata3*-deficient NK cells from the BM.

The ability of BM NK cells to migrate in response to the CXCR4 ligand, CXCL12, was assessed in vitro using the transwell migration assay. Pretreatment with AMD3100 reduced the chemotaxis of NK cells from *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice but did not affect the migration of NK cells from control littermates (Fig. 5F), suggesting that chemotaxis to CXCL12 is responsible for the retention of iNK cells of *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice in the BM. Notably, NK cells in the BM of *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice showed higher expression of CXCR4 (Fig. 5G, 5H). Taken together, GATA3 is required for the CXCR4 downmodulation associated with mature NK cell phenotype, and CXCR4-mediated retention is a major mechanism for the abundant NK cell proportion in the BM of *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice.

## Requirement of GATA3 for IFN-γ production by NK cells

It was previously shown that in the absence of GATA3, NK cells are defective in producing IFN-γ when stimulated through the surface receptor CD11b or using IL-12 and IL-18 (30). The defective IFN-γ production might be due to the reduced expression of surface CD11b or cytokine receptors. In addition, the ability of *Gata3*-deficient NK cells to produce IFN-γ has not been thoroughly shown via stimulation of NK-activating receptors. Thus, we tested whether cross-linking of the activating receptors NK1.1 and Ly49H would result in reduced production of IFN-γ in the absence of GATA3. The expression of surface NK1.1 was comparable between *NKp46-Cre-Gata3*<sup>fl/fl</sup> and control mice. In vitro stimulation through NK1.1 resulted in similar frequencies of NK cells producing IFN-γ for both *NKp46-Cre-Gata3*<sup>fl/fl</sup> and control mice (Fig. 6A, 6B), indicating that stimulation through an activating receptor can lead to normal cytokine production by NK cells in the absence of GATA3. When stimulated through Ly49H, slightly less NK cells were able to produce IFN-γ in the absence of GATA3, but this might be explained by the moderate reduction of Ly49H<sup>+</sup> NK cell proportions in *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice (Fig. 4A, 4B). The role of GATA3 on IFN-γ production was also investigated upon cytokine stimulation. When NK cells were stimulated with different combinations of cytokines such as IL-2, IL-12, and IL-18, *Gata3*-deficient splenic NK cells exhibited a reduced ability to produce IFN-γ. NK cell degranulation evaluated by the LAMP-1 expression was largely comparable between NK cells from *NKp46-Cre-Gata3*<sup>fl/fl</sup> and control mice. Taken together, GATA3 is largely

<figure><img src="image_13.png" /><figcaption>B</figcaption></figure>

<figure><img src="image_14.png" /></figure>

**FIGURE 6.** IFN-γ production of splenic NK cells from *NKp46-Cre-Gata3*<sup>fl/fl</sup> mice. IFN-γ production is measured in NK cells from *NKp46-Cre-Gata3*<sup>fl/fl</sup> and *Gata3*<sup>fl/fl</sup> mice following cytokine stimulation or stimulation of activating receptors. (A) Representative plots of intracellular IFN-γ in NK cells from *NKp46-Cre-Gata3*<sup>fl/fl</sup> or *Gata3*<sup>fl/fl</sup> mice upon stimulation with the indicated Abs or cytokines. (B) Percentage of IFN-γ-producing NK cells (NK1.1<sup>+</sup>TCR-β<sup>-</sup>) from control (white bars) or *NKp46-Cre-Gata3*<sup>fl/fl</sup> (black bars) mice upon stimulation with the indicated Abs or cytokines. Data are from one experiment representative of two independent experiments, with three replicates per group. Data represent mean + SD. **p** < 0.01, ***p** < 0.001.

dispensable for induction of effector functions in response to stimulation of activating receptors, but is required for efficient IFN-γ production in response to cytokines.
<figure><img src="image_15.png" /><figcaption>**FIGURE 7.** Upon MCMV infection, NK cells from *NKp46-Cre-Gata3<sup>fl/fl</sup>* mice expand robustly. *NKp46-Cre-Gata3<sup>fl/fl</sup>* or *Gata3<sup>fl/fl</sup>* mice were either uninfected or given 5000 PFU MCMV i.p. and sacrificed on days 1.5, 2.5, or 3 postinfection for the following analyses: (A) NK cells from spleens and livers of naive (D0) or MCMV-infected mice (D1.5) were stained for IFN-γ production. (B) Number of NK cells producing IFN-γ in spleen and liver of *Gata3<sup>fl/fl</sup>* (white bars) or *NKp46-Cre-Gata3<sup>fl/fl</sup>* (black bars) mice. (C) Serum levels of IFN-γ and IL-12 in indicated groups at days 0 and 1.5 postinfection. (D) Viral burden in spleen and liver of *Gata3<sup>fl/fl</sup>* (white circles) or *NKp46-Cre-Gata3<sup>fl/fl</sup>* (black circles) mice at day 3 postinfection. (E) Representative plots of NK cell frequencies (NK1.1<sup>+</sup>TCR-β<sup>-</sup>) in spleens and livers of naive (D0) or MCMV-infected (D3) mice. (F) Percentage of NK cells (NK1.1<sup>+</sup>TCR-β<sup>-</sup>) in *Gata3<sup>fl/fl</sup>* (white bars) or *NKp46-Cre-Gata3<sup>fl/fl</sup>* (black bars) mice at days 0 and 3 postinfection. (G and H) Percentage of Ki-67<sup>+</sup> NK cells in the liver of naive and infected mice at day 2.5. (I) GATA3 expression in NK cells from *NKp46-Cre-Gata3<sup>fl/fl</sup>* or *Gata3<sup>fl/fl</sup>* mice at day 3 postinfection. (J) The cytotoxicity of NK cells of *NKp46-Cre-Gata3<sup>fl/fl</sup>* or *Gata3<sup>fl/fl</sup>* mice against YAC-1 target cells is depicted. For (A)–(E) and (G)–(J), data are from one experiment representative of two independent experiments, with two to five mice per group. For (F), data were pooled from two independent experiments, with three to nine mice per group. Data represent mean + SD. For (D), horizontal lines indicate the mean. \*p < 0.05, \*\*p < 0.01, \*\*\*p < 0.001. ND, not detected.</figcaption></figure>
<figure><img src="image_16.png" /><figcaption>C</figcaption></figure>

<figure><img src="image_17.png" /><figcaption>D</figcaption></figure>

<figure><img src="image_18.png" /><figcaption>B</figcaption></figure>

<figure><img src="image_19.png" /><figcaption>E</figcaption></figure>

<figure><img src="image_20.png" /><figcaption>F</figcaption></figure>

<figure><img src="image_21.png" /><figcaption>G</figcaption></figure>

<figure><img src="image_22.png" /><figcaption>H</figcaption></figure>

<figure><img src="image_23.png" /><figcaption>I</figcaption></figure>

<figure><img src="image_24.png" /></figure>

**FIGURE 8.** NK cells from *NKp46-Cre-Gata3fl/fl* mice express higher levels of CD25 upon activation and show enhanced proliferation upon stimulation with low doses of IL-2 in vitro. (**A** and **B**) *NKp46-Cre-Gata3fl/fl* or *Gata3fl/fl* mice were either uninfected or given 5000 PFU MCMV i.p. and sacrificed on day 1.5 postinfection. NK cell from spleens and livers of naive (D0) or MCMV-infected mice (D1.5) were surface stained for CD25. (**C**) Representative plots of CD25 expression in NK cells following stimulation with IL-12 and/or IL-18 for 24 h. (**D**) Percentage of CD25-expressing NK cells from *Gata3fl/fl* (white bars) or *NKp46-Cre-Gata3fl/fl* (black bars) mice when stimulated with IL-12 and/or IL-18. (**E**) Representative plots of IL-12Rβ2 and IL-18Rα expression on unstimulated NK cells. (**F**) Percentage of IL-12Rβ2+ and IL-18Rα+ expressing unstimulated NK cells from *Gata3fl/fl* (white bars) or *NKp46-Cre-Gata3fl/fl* (black bars) mice. (**G**) Total STAT4 and p-STAT4 expression in unstimulated or IL-12- and IL-18-stimulated NK cells from *Gata3fl/fl* or *NKp46-Cre-Gata3fl/fl* mice. (**H** and **I**) Enriched NK cell from spleens of *NKp46-Cre-Gata3fl/fl* or *Gata3fl/fl* littermates were labeled with a cell division dye and stimulated with IL-2. (H) Histograms depict the proliferation and CD25 expression of NK cells following 5 d of culture with the indicated concentrations of IL-2. (I) Percentage of divided NK cells and CD25-expressing NK cells when cultured for 5 d with the indicated (Figure legend continues)
### NK cells from NKp46-Cre-Gata3 flox/flox mice robustly expand during MCMV infection

During MCMV infection, cytokine levels in the serum peak at day 1.5, whereas the proportion of proliferating NK cells reaches its peak at day 3 (50, 51). To determine whether the defect in cytokine production observed in vitro can also be seen in vivo, we measured the production of IFN-γ by NK cells from NKp46-Cre-Gata3 flox/flox mice upon challenge with MCMV. Following infection with MCMV, increased NK cell frequencies were found in the livers, presumably due to cell migration to the liver (52). Fewer NK cells in the spleens and livers of NKp46-Cre-Gata3 flox/flox mice produced IFN-γ in vivo at day 1.5 post-MCMV infection (Fig. 7A, 7B). IFN-γ production at day 1.5 of MCMV infection is largely mediated by IL-12 (53, 54). However, IFN-γ and IL-12 levels in the serum of NKp46-Cre-Gata3 flox/flox mice were similar to their control littermates (Fig. 7C). When we compared IFN-γ expression in subsets of distinct maturation stages, CD27 SP and DP NK cells were the most efficient at producing IFN-γ (Supplemental Fig. 2A, 2B).

We next investigated whether this defect in IFN-γ production in combination with the reduced NK cell frequencies in the periphery would render the NKp46-Cre-Gata3 flox/flox mice highly susceptible to viral infection. Interestingly, we observed only a slightly higher viral burden in the spleens and similar viral burden in the livers of NKp46-Cre-Gata3 flox/flox mice at day 3 following infection (Fig. 7D). In order to explain this unexpected resistance in NKp46-Cre-Gata3 flox/flox mice, we analyzed the NK cell populations in these mice. Surprisingly, despite their reduced numbers in the spleen and liver at the steady state, following MCMV infection, NK cells from NKp46-Cre-Gata3 flox/flox mice were able to expand to similar frequencies as NK cells from control littermates (Fig. 7E, 7F). In particular, the proportions of NK cells in the liver were greatly increased and associated with increased proliferation of liver NK cells at day 2.5 postinfection based on Ki-67 staining (Fig. 7G, 7H). CD27 SP and DP NK cells showed the highest levels of proliferation (Supplemental Fig. 2E, 2F). When we compared Ki-67 expression in subsets of distinct maturation stages, the expression was similar in NK cell subsets of equivalent maturation stages, indicating that the higher proportion of iNK cells contained in total NK cells of NKp46-Cre-Gata3 flox/flox mice explain the increased Ki-67 expression. To exclude the possibility that these expanded cells originate from residual GATA3⁺ NK cells in which the Cre recombination failed to occur, we measured GATA3 expression in the expanded NK cells from day 3 post-MCMV infection. The expanded NK cells in NKp46-Cre-Gata3 flox/flox mice did not express GATA3 (Fig. 7I). Not only were NK cells from NKp46-Cre-Gata3 flox/flox mice able to expand during MCMV infection, but they were also able to execute their cytotoxic functions, as shown by killing assay (Fig. 7J).

### The enhanced proliferation of NK cells from NKp46-Cre-Gata3 flox/flox mice is cell intrinsic

In order to be able to bind to IL-2 with high affinity and therefore to respond to low levels of physiological IL-2 concentrations in vivo, NK cells need to express IL-2Rα (CD25) to complete the heterotrimeric high-affinity IL-2R composed of IL-2Rα, β, and the common γ-chain (55). During MCMV infection, IL-12 and IL-18 can induce the upregulation of CD25 (56). Following MCMV infection, NK cells from NKp46-Cre-Gata3 flox/flox mice expressed higher levels of CD25 than NK cells from control mice (Fig. 8A,

8B, Supplemental Fig. 2C, 2D), which could explain the enhanced proliferation of these cells. To exclude the effect of differential inflammation during MCMV infection, we cultured naive splenic NK cells from NKp46-Cre-Gata3 flox/flox mice and control littermates in the presence of IL-12 and IL-18 to measure the upregulation of CD25 in vitro. NK cells from NKp46-Cre-Gata3 flox/flox mice were more efficient at upregulating CD25 as compared with NK cells from control littermates (Fig. 8C, 8D), and this was not due to increased levels of IL-12 in the serum (Fig. 7C). Interestingly, the enhanced CD25 expression was observed despite reduced IL-18Rα expression on GATA3-deficient NK cells (Fig. 8E, 8F). IL-12Rβ2 expression was similar between the NKp46-Cre-Gata3 flox/flox and control mice. CD27 SP and DP NK cells populations were the most efficient at upregulating CD25 upon stimulation with IL-12 and IL-18, respectively (Supplemental Fig. 3A, 3B). Similar to the Ki-67 expression, CD25 expression in all subsets in both NKp46-Cre-Gata3 flox/flox and control littermates was equivalent, indicating that the higher proportion of immature NK cells in NKp46-Cre-Gata3 flox/flox mice explain the increased CD25 expression. The reduced expression of IL-18Rα might explain the decreased CD25 expression upon IL-18 stimulation on NK cells of NKp46-Cre-Gata3 flox/flox mice (Supplemental Fig. 3C, 3D).

STAT4 is required for CD25 induction upon IL-12 stimulation during MCMV infection (56). Expression of total STAT4 was similar between the two groups (Fig. 8G), and stimulation with IL-12 and IL-18 led to similar phosphorylation levels of STAT4 in NK cells from NKp46-Cre-Gata3 flox/flox mice. Because NK cells from NKp46-Cre-Gata3 flox/flox mice expand robustly during MCMV infection in vivo, we next sought to determine whether naive splenic NK cells are more responsive than control NK cells when stimulated with IL-2 in vitro. NK cells from NKp46-Cre-Gata3 flox/flox showed enhanced proliferation upon stimulation with low doses of IL-2 (Fig. 8H, 8I, Supplemental Fig. 3E, 3F). It could be explained by increased upregulation of CD25 on NK cells from NKp46-Cre-Gata3 flox/flox mice compared with those from control littermates. Indeed, enriched NK cells from NKp46-Cre-Gata3 flox/flox mice displayed higher expression of CD25 when cultured for 5 d at low doses of IL-2 (Fig. 8H, 8I). Therefore, splenic NK cells from NKp46-Cre-Gata3 flox/flox mice exhibited intrinsically enhanced CD25 expression and proliferative ability. Similar hyperresponsiveness of NK cells from NKp46-Cre-Gata3 flox/flox mice was observed in response to IL-15 (Supplemental Fig. 3G, 3H).

During MCMV infection, the increased proliferation of NK cells from NKp46-Cre-Gata3 flox/flox mice may result from higher viral load and/or higher inflammation compared with control littermates. Therefore, to investigate whether the enhanced proliferative potential of NK cells from NKp46-Cre-Gata3 flox/flox mice is cell intrinsic, we adoptively transferred equal numbers of Ly49H⁺ NK cells from either control or NKp46-Cre-Gata3 flox/flox (CD45.2⁺) spleen into Ly49H-deficient (CD45.1⁺) recipient mice. The recipient mice were either infected with MCMV 1 d later or left uninfected before being sacrificed 5 d postinfection (Fig. 9A). In both spleen and liver, we observed greater expansion of donor NK cells when these cells originated from NKp46-Cre-Gata3 flox/flox mice (Fig. 9B, 9C), indicating that NK cells in NKp46-Cre-Gata3 flox/flox mice show an intrinsically enhanced proliferative capability.
<figure><img src="image_25.png" /></figure>

<figure><img src="image_26.png" /><figcaption>FIGURE 9. NK cells from *NKp46-Cre-Gata3<sup>fl/fl</sup>* mice show enhanced expansion in a cell-intrinsic manner. (A) Diagram of chimera generation and experimental design. Spleen cells from *Gata3<sup>fl/fl</sup>* or *NKp46-Cre-Gata3<sup>fl/fl</sup>* mice (CD45.2<sup>+</sup>) were isolated and transferred into Ly49H<sup>-/-</sup> recipients (CD45.1<sup>+</sup>). Ly49H<sup>-/-</sup> were either uninfected or given 3000 PFU MCMV i.p. 1 d following adoptive transfer. Leukocytes from spleen and liver of recipient mice were harvested on day 5 postinfection. (B) Representative plots of transferred cells (Ly49H<sup>+</sup>CD45.2<sup>+</sup>) in spleen and liver of recipient mice at day 5 gated on DX5<sup>+</sup>TCRβ<sup>-</sup> cells. (C) Percentage of transferred cells from *Gata3<sup>fl/fl</sup>* (white bars) or *NKp46-Cre-Gata3<sup>fl/fl</sup>* (black bars) mice in spleens and livers of recipient mice at day 5. Data are from one experiment representative of two independent experiments, with two to four mice per group. Data represent mean ± SD. \*p < 0.05, \*\*\*p < 0.001.</figcaption></figure>

Discussion

In the study, we investigated the NKp46-Cre-driven *Gata3*-deficient mice. Compared to *Vav-Cre-Gata3<sup>fl/fl</sup>* mice for which *Gata3* deficiency is induced in all hematopoietic cells at the early stage of development (31), *NKp46-Cre-Gata3<sup>fl/fl</sup>* mice provide a mouse model that allows us to study the roles of GATA3 at a late stage of NK development in a cell-intrinsic manner. We identified a critical role of GATA3 in the NK cell maturation stage associated with seeding of peripheral organs, highlighted by increased numbers of NK cell in the BM and decreased numbers in the peripheral organs of *NKp46-Cre-Gata3<sup>fl/fl</sup>* mice. Interestingly, intact frequencies of NK1.1<sup>+</sup> cNK cells were found in the spleens of *Vav-Cre-Gata3<sup>fl/fl</sup>* mice, suggesting that *Gata3* deficiency at the early stage of NK cell development might allow an alternative pathway of BM egress

(31). Otherwise, the developmental defect in other immune cells in the absence of GATA3 might alleviate the defect in NK cell maturation.

Liver-resident NK cells are different from cNK but share many characteristics with ILC1s, as they express NK1.1, NKp46, and CD49a and require T-bet for their development (23–25, 57, 58). In contrast to its dispensable role in the development of cNK precursor cells, GATA3 is important in the development of multiple ILCs. GATA3 was initially identified to be essential in ILC2 maintenance in mice and humans (59–61). More recently, GATA3 was shown to be essential for the generation of the common progenitor cells for IL-7Rα-expressing ILCs. In the studies using *Vav-Cre-Gata3<sup>fl/fl</sup>* mice or chimeric mice generated with *Gata3*-deficient fetal liver hematopoietic precursor cells, several ILC subsets including ILC2s and ILC3s were severely affected in the absence of GATA3 during their development (31, 62). Higher proportions of liver-resident NK cells were present in *Vav-Cre-Gata3<sup>fl/fl</sup>* mice compared with controls; however, the absolute numbers of those cells were not provided (25). Therefore, our data showing reduced numbers of liver-resident NK cells in *NKp46-Cre-Gata3<sup>fl/fl</sup>* mice are rather surprising. It is possible that deletion of other immune cells due to the early deletion of *Gata3* might provide an advantageous environment for the generation of liver-resident NK cells. Similarly, frequencies of ILC1s were found decreased in the absence of GATA3 (58).

NK cells developing in the absence of GATA3 showed a defect in exiting the BM at the steady state. NK cells displayed an immature phenotype characterized by an accumulation of the CD27<sup>+</sup>CD11b<sup>-</sup> subset in the BM, spleens, and livers, demonstrating that GATA3 is required for the NK cell maturation beyond the CD27 SP stage. More recently, *Ikzf3* was reported to be required for the maturation in the spleen of CD27<sup>-</sup>CD11b<sup>+</sup> NK cells, suggesting that IKZF3 regulates the maturation of NK cells subsequent to GATA3 (63). Interestingly, the iNK cells exhibited lower expression of adhesion molecules such as CD11b and CD62L. It has been shown that NK cells that enter the BM sinusoids are mainly mature NK cells that express CD11b (37). During development, the BM egress of NK cells is mainly regulated by two independent events, CXCR4 desensitization and sphingosine-1-phosphate receptor 5 (S1P5) engagement (37). The chemokine receptor CXCR4 was shown to retain iNK cells in the BM, and CXCR4 expression is negatively correlated with NK cell maturation. In this study, we tested the ability of NK cells from *NKp46-Cre-Gata3<sup>fl/fl</sup>* mice to exit the BM by using AMD3100, a CXCR4 antagonist. Treatment of *NKp46-Cre-Gata3<sup>fl/fl</sup>* with AMD3100 resulted in the egress of the immature CD27 SP NK cells from the BM to the blood. Moreover, our transwell migration assay indicated that NK cells from *NKp46-Cre-Gata3<sup>fl/fl</sup>* mice exhibit reduced chemotaxis in response to CXCL12 upon ADM3100 treatment. Therefore, sustained CXCR4 expression on NK cells in the BM of *NKp46-Cre-Gata3<sup>fl/fl</sup>* mice blocks the migration of NK from the BM to the periphery. Antagonizing CXCR4 by AMD3100 could be used in clinical settings for patients who carry genetic defects that lead to low numbers of peripheral NK cells due to their incomplete maturation.

The migratory defects observed in NK cells from *NKp46-Cre-Gata3<sup>fl/fl</sup>* mice are similar to those in *S1P5*-deficient, *Prmd1*-deficient, and *T-bet*-deficient mice (38, 64, 65), showing higher proportions of NK cells in the BM and reduced proportions of NK cells in the periphery. T-bet acts upstream of Blimp1 in mouse NK cells (65), and T-bet expression is regulated by GATA3 (30) (Supplemental Fig. 1). More importantly, S1P5 is a direct target of
T-bet and its expression is significantly reduced on NK cells from T-bet-deficient mice (64). Thus, the reduced expression of T-bet observed in *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice might be responsible for the migratory defect of NK cells. Similarly, Foxo1, a negative regulator in the late stage of NK cell maturation, represses T-bet (66). Unfortunately, we could not evaluate the expression of S1P5 on NK cells due to the lack of available good Abs.

Our data indicated that NK cells from *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice exhibit defective IFN-γ production when stimulated by cytokines, consistent with a previous report (30). At least the defective IFN-γ production in response to IL-12 is not likely explained by the levels of cytokine receptor expression because the expression of the inducible IL-12Rβ2 chain is comparable (67). The defect seems to be narrowed to the response to cytokines, because stimulation through activating receptors such as NK1.1 or Ly49H showed comparable IFN-γ production with control littermates. In addition, the cytotoxic function of NK cells from MCMV-infected *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice was intact, suggesting that stimulatory signals through activating receptors on NK cells from *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice are largely intact and capable of inducing cytokine production and cytotoxicity.

Despite having iNK cells with reduced frequencies in the peripheral organs, *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice controlled the virus to a similar extent as their control littermates on day 3 postinfection. Remarkably, the frequencies of NK cells in spleens and livers of *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice reached similar numbers to NK cells from control littermates. The robust NK cell expansion can be explained by the enhanced proliferative capability of NK cells from *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice. The increased proliferative capability was cell intrinsic, as NK cells from *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice divided more robustly in response to IL-2 or IL-15 than NK cells from control mice in vitro. Adoptive transfer experiments supported that the heightened proliferative ability of NK cells from *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice was cell intrinsic. Finally, the enhanced proliferation of NK cells from *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice was associated with increased CD25 expression, which allowed NK cells to efficiently respond to low doses of IL-2. Similar to the aforementioned defective IFN-γ response to IL-12, the increased expression of CD25 is not explained by dysregulated IL-12 and/or IL-18 cytokine receptors. Despite the reduced IL-18 receptor expression, IL-18 stimulation induced comparable levels of CD25 expression. Moreover, higher CD25 induction was observed on NK cells in *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice, whereas the level of STAT4, which is a critical transcription factor for inducing CD25 upon IL-12, was comparable, and STAT4 was phosphorylated at a similar degree upon IL-12/IL-18 stimulation. There have been indications that iNK cells exhibit great proliferative capacity regardless of stimulation. In the BM, DX5<sup>+</sup>CD27<sup>+</sup>CD11b<sup>-</sup> NK cells actively proliferate under steady-state conditions (12, 68). During MCMV infection, CD11b<sup>low</sup> NK cells proliferate more than CD11b<sup>high</sup> NK cells at day 2 postinfection (68). In addition, CD11b<sup>-</sup> NK cells show enhanced proliferation as compared with CD11b<sup>+</sup> NK cells when stimulated in vitro with IL-15 (69). Similarly, NK cells from *Ets1*-deficient mice showed reduced maturation and were hyperresponsive to IL-15 (70). Notably, a study also demonstrated cell-specific gene regulation by *Gata3* by revealing a list of genes that are differentially regulated in ILC2 and Th2 cells (31). In contrast to CD25 upregulation on NK cells in our model during viral infection, GATA3 positively regulates CD25 expression on ILC2s, but not ILC3s (31). Similarly, *Gata3* deletion did not reduce the expression of *Klrg1* and *Id2* in ILC2s. Altogether, these results indicated the stage- and cell-specific roles of GATA3 during ILC development. Therefore, it might be interesting to know whether CD25 upregulation on NK

cells in *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice is regulated by developmental stage-specific epigenetic modifications in the Cd25 locus. The differential binding of GATA3 on the NKG2A promoter region of human NK cells but not Jurkat T cells supports the influence of epigenetic regulations on the roles of GATA3 (71).

Taken together, we dissected the role of GATA3 in regulating the development of NK cells. Even though GATA3 is largely dispensable for the generation of cNK cells, it has a significant impact on the maturation of NK cells, resulting in a migratory defect in BM egress in the absence of GATA3. Notably, peripheral iNK cells of *Nkp46-Cre-Gata3*<sup>fl/fl</sup> mice expand more than mNK cells from control littermates during MCMV infection, allowing rapid accumulation of NK cells with intact cytotoxicity. Our data demonstrated that iNK cells hold a higher intrinsic proliferative capability and can serve as a reservoir of cytotoxic NK cells upon infection and therefore will advance our understanding of the antiviral NK cell response in individuals who have defects in NK cell maturation.

## Acknowledgments

We thank Almohanad Alkayyal in Dr. Rebecca Auer's laboratory at Ottawa Hospital Research Institute for help with the transwell migration assay. We also thank the National Institutes of Health/National Cancer Institute at Frederick Biological Resources Branch Preclinical Repository for providing the rhIL-2 cytokine.

## Disclosures

E.V. is a cofounder and shareholder of Innate-Pharma. The other authors have no financial conflicts of interest.

## References

1. Herberman, R. B., M. E. Nunn, and D. H. Lavrin. 1975. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic allogeneic tumors. I. Distribution of reactivity and specificity. *Int. J. Cancer* 16: 216-229.

2. Kiessling, R., E. Klein, and H. Wigzell. 1975. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. *Eur. J. Immunol.* 5: 112-117.

3. Vitale, M., M. Della Chiesa, S. Carlomagno, D. Pende, M. Aricò, L. Moretta, and A. Moretta. 2005. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. *Blood* 106: 566-571.

4. Biron, C. A., and L. Brossay. 2001. NK cells and NKT cells in innate defense against viral infections. *Curr. Opin. Immunol.* 13: 458-464.

5. Lee, S. H., T. Miyagi, and C. A. Biron. 2007. Keeping NK cells in highly regulated antiviral warfare. *Trends Immunol.* 28: 252-259.

6. Cichocki, F., E. Sitnicka, and Y. T. Bryceson. 2014. NK cell development and function-plasticity and redundancy unleashed. *Semin. Immunol.* 26: 114-126.

7. Hesslein, D. G., and L. L. Lanier. 2011. Transcriptional control of natural killer cell development and function. *Adv. Immunol.* 109: 45-85.

8. Eckelhart, E., W. Warsch, E. Zebedin, O. Simma, D. Stoiber, T. Kolbe, T. Rülicke, M. Mueller, E. Casanova, and V. Sexl. 2011. A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. *Blood* 117: 1565-1573.

9. Park, S. Y., K. Saijo, T. Takahashi, M. Osawa, H. Arase, N. Hirayama, K. Miyake, H. Nakauchi, T. Shirasawa, and T. Saito. 1995. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. *Immunity* 3: 771-782.

10. Nandagopal, N., A. K. Ali, A. K. Komal, and S. H. Lee. 2014. The Critical Role of IL-15-PI3K-mTOR Pathway in Natural Killer Cell Effector Functions. *Front. Immunol.* 5: 187.

11. Chiossone, L., J. Chaix, N. Fuseri, C. Roth, E. Vivier, and T. Walzer. 2009. Maturation of mouse NK cells is a 4-stage developmental program. *Blood* 113: 5488-5496.

12. Hayakawa, Y., and M. J. Smyth. 2006. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. *J. Immunol.* 176: 1517-1524.

13. Huntington, N. D., C. A. Vosshenrich, and J. P. Di Santo. 2007. Developmental pathways that generate natural-killer-cell diversity in mice and humans. *Nat. Rev. Immunol.* 7: 703-714.

14. Male, V., and H. J. Brady. 2014. Transcriptional control of NK cell differentiation and function. *Curr. Top. Microbiol. Immunol.* 381: 173-187.

15. Sun, X. H., N. G. Copeland, N. A. Jenkins, and D. Baltimore. 1991. Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. *Mol. Cell. Biol.* 11: 5603-5611.
16. Intlekofer, A. M., N. Takemoto, E. J. Wherry, S. A. Longworth, J. T. Northrup, V. R. Palanivel, A. C. Mullen, C. R. Gasink, S. M. Kaech, J. D. Miller, et al. 2005. Effector and memory CD8+ T cell fate coupled by T-bet and esomesodermin. *Nat. Immunol.* 6: 1236-1244.

17. Kamizono, S., G. S. Duncan, M. G. Seidel, A. Morimoto, K. Hamada, G. Grosveld, A. Akashi, E. F. Lind, J. P. Haight, P. S. Ohashi, et al. 2009. Nf13/ E4bp4 is required for the development and maturation of NK cells in vivo. *J. Exp. Med.* 206: 2977-2986.

18. Male, V., I. Nisoli, T. Kostrzewski, D. S. Allan, J. R. Carlyle, G. M. Lord, A. Wack, and H. J. Brady. 2014. The transcription factor E4bp4/Nf13 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression. *J. Exp. Med.* 211: 635-642.

19. Yang, M., D. Li, Z. Chang, Z. Yang, Z. Tian, and Z. Dong. 2015. PDK1 or- chestrates early NK cell development through induction of E4BP4 expression and maintenance of IL-15 responsiveness. *J. Exp. Med.* 212: 253-265.

20. Beima, K. M., M. M. Miazgowicz, M. D. Lewis, P. S. Yan, T. H. Huang, and A. S. Weinmann. 2006. T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. *J. Biol. Chem.* 281: 11992-12000.

21. Vosshenrich, C. A., M. E. García-Ojeda, S. I. Samson-Villéger, V. Pasqualetto, L. Enault, O. Richard-Le Goff, E. Corcuff, D. Guy-Grand, B. Rocha, A. Cumano, et al. 2006. A thymic pathway of mouse natural killer cell devel- opment characterized by expression of GATA-3 and CD127. *Nat. Immunol.* 7: 1217-1224.

22. Takeda, K., E. Cretney, Y. Hayakawa, T. Ota, H. Akiba, K. Ogasawara, H. Yagita, K. Kinoshita, K. Okumura, and M. J. Smyth. 2005. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. *Blood* 105: 2082-2089.

23. Gordon, S. M., J. Chaix, L. J. Rupp, J. Wu, S. Madera, J. C. Sun, T. Lindsten, and S. L. Reiner. 2012. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. *Immunity* 36: 55-67.

24. Peng, H., X. Jiang, Y. Chen, D. K. Sojka, H. Wei, X. Gao, R. Sun, W. M. Yokoyama, and Z. Tian. 2013. Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. *J. Clin. Invest.* 123: 1444-1456.

25. Sojka, D. K., B. Plougastel-Douglas, L. Yang, M. A. Pak-Wittel, M. N. Artyomov, Y. Ivanova, C. Zhong, J. M. Chase, P. B. Rothman, J. Yu, et al. 2014. Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. *eLife* 3: e01659.

26. Evans, T., M. Reitman, and G. Felsenfeld. 1988. An erythrocyte-specific DNA- binding factor recognizes a regulatory sequence common to all chicken globin genes. *Proc. Natl. Acad. Sci. USA* 85: 5976-5980.

27. Tindemans, I., N. Serafini, J. P. Di Santo, and R. W. Hendriks. 2014. GATA3- function in innate and adaptive immunity. *Immunity* 41: 191-206.

28. Ting, C. N., M. C. Olson, K. P. Barton, and J. M. Leiden. 1996. Transcription factor GATA-3 is required for development of the T-cell lineage. *Nature* 384: 474-478.

29. Wan, Y. Y. 2014. GATA3: a master of many trades in immune regulation. *Trends Immunol.* 35: 233-242.

30. Samson, S. I., O. Richard, M. Tavian, T. Ranson, C. A. Vosshenrich, F. Colucci, J. Buer, F. Grosveld, I. Godin, and J. P. Di Santo. 2003. GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. *Immunity* 19: 701-711.

31. Yagi, R., C. Zhong, D. L. Northrup, F. Yu, N. Bouladoux, S. Spencer, G. Hu, L. Barron, S. Sharma, T. Nakayama, et al. 2014. The transcription factor GATA3 is critical for the development of all IL-7Rα-expressing innate lymphoid cells. *Immunity* 40: 378-388.

32. Narni-Mancinelli, E., J. Chaix, A. Fenis, Y. M. Kerdiles, N. Yessaad, A. Reynders, C. Gregoire, H. Luche, S. Ugolini, E. Tomasello, et al. 2011. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. *Proc. Natl. Acad. Sci. USA* 108: 18324-18329.

33. Grote, D., S. K. Boualia, A. Souabni, C. Merkel, X. Chi, F. Costantini, T. Carroll, and M. Bouchard. 2008. Gata3 acts downstream of beta-catenin signaling to prevent ectopic metanephric kidney induction. *PLoS Genet.* 4: e1000316.

34. Grote, D., A. Souabni, M. Busslinger, and M. Bouchard. 2006. Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. *Development* 133: 53-61.

35. Fodil-Cornu, N., S. H. Lee, S. Belanger, A. P. Makrigiannis, C. A. Biron, R. M. Buller, and S. M. Vidal. 2008. Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. *J. Immunol.* 181: 6394-6405.

36. Lee, S. H., A. Zafer, Y. de Repentigny, R. Kothary, M. L. Tremblay, P. Gros, P. Duplay, J. R. Webb, and S. M. Vidal. 2003. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. *J. Exp. Med.* 197: 515-526.

37. Mayol, K., V. Biajoux, J. Marvel, K. Balabanian, and T. Walzer. 2011. Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking. *Blood* 118: 4863-4871.

38. Walzer, T., L. Chiossone, J. Chaix, A. Calver, C. Carozzo, L. Garrigue-Antar, Y. Jacques, M. Baratin, E. Tomasello, and E. Vivier. 2007. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. *Nat. Immunol.* 8: 1337-1344.

39. Lim, K. C., G. Lakshmanan, S. E. Crawford, Y. Gu, F. Grosveld, and J. D. Engel. 2000. Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. *Nat. Genet.* 25: 209-212.

40. Wang, Y., I. Misumi, A. D. Gu, T. A. Curtis, L. Su, J. K. Whitmire, and Y. Y. Wan. 2013. GATA-3 controls the maintenance and maturation of T cells downstream of TCR and cytokine signaling. *Nat. Immunol.* 14: 714-722.

41. Gascoyne, D. M., E. Long, H. Veiga-Fernandes, J. de Boer, O. Williams, B. Seddon, M. Coles, D. Kioussis, and H. J. Brady. 2009. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. *Nat. Immunol.* 10: 1118-1124.

42. Boos, M. D., Y. Yokota, G. Eberl, and B. L. Kee. 2007. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. *J. Exp. Med.* 204: 1199-1130.

43. Townsend, M. J., A. S. Weinmann, J. L. Matsuda, R. Salomon, P. J. Farnham, C. A. Biron, L. Gapin, and L. H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. *Immunity* 20: 477- 494.

44. Aliahmad, P., B. de la Torre, and J. Kaye. 2010. Shared dependence on the DNA- binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. *Nat. Immunol.* 11: 945-952.

45. Luo, B. H., and T. A. Springer. 2006. Integrin structures and conformational signaling. *Curr. Opin. Cell Biol.* 18: 579-586.

46. Wendel, M., I. E. Galani, E. Suri-Payer, and A. Cerwenka. 2008. Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands. *Cancer Res.* 68: 8437-8445.

47. Bernardini, G., G. Benigni, F. Antonangeli, A. Ponzetta, and A. Santoni. 2014. Multiple levels of chemokine receptor regulation in the control of mouse natural killer cell development. *Front. Immunol.* 5: 44.

48. Bernardini, G., G. Sciumè, D. Bosisio, S. Morrone, S. Sozzani, and A. Santoni. 2008. CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. *Blood* 111: 3626-3634.

49. Bernardini, G., G. Sciumè, and A. Santoni. 2013. Differential chemotactic receptor requirements for NK cell subset trafficking into bone marrow. *Front. Immunol.* 4: 12.

50. Lee, S. H., K. S. Kim, N. Fodil-Cornu, S. M. Vidal, and C. A. Biron. 2009. Activating receptors promote NK cell expansion for maintenance, IL-10 pro- duction, and CD8 T cell regulation during viral infection. *J. Exp. Med.* 206: 2235-2251.

51. Tarrio, M. L., S. H. Lee, M. F. Fragoso, H. W. Sun, Y. Kanno, J. J. O'Shea, and C. A. Biron. 2014. Proliferation conditions promote intrinsic changes in NK cells for an IL-10 response. *J. Immunol.* 193: 354-363.

52. Salazar-Mather, T. P., J. S. Orange, and C. A. Biron. 1998. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. *J. Exp. Med.* 187: 1-14.

53. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X. Q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell re- sponses to viral infection. *J. Immunol.* 169: 4279-4287.

54. Orange, J. S., and C. A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. *J. Immunol.* 156: 1138-1142.

55. Boyman, O., and J. Sprent. 2012. The role of interleukin-2 during homeostasis and activation of the immune system. *Nat. Rev. Immunol.* 12: 180-190.

56. Lee, S. H., M. F. Fragoso, and C. A. Biron. 2012. Cutting edge: a novel mechanism bridging innate and adaptive immunity: IL-12 induction of CD25 to form high-affinity IL-2 receptors on NK cells. *J. Immunol.* 189: 2712-2716.

57. Daussy, C., F. Faure, K. Mayol, S. Viel, G. Gasteiger, E. Charrier, J. Bienvenu, T. Henry, E. Debien, U. A. Hasan, et al. 2014. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. *J. Exp. Med.* 211: 563-577.

58. Klose, C. S., M. Flach, L. Möhle, L. Rogell, T. Hoyler, K. Ebert, C. Fabiunke, D. Pfeifer, V. Sexl, D. Fonseca-Pereira, et al. 2014. Differentiation of type I LILCs from a common progenitor to all helper-like innate lymphoid cell lineages. *Cell* 157: 340-356.

59. Furusawa, J., K. Moro, Y. Motomura, K. Okamoto, J. Zhu, H. Takayanagi, M. Kubo, and S. Koyasu. 2013. Critical role of p38 and GATA3 in natural helper cell function. *J. Immunol.* 191: 1818-1826.

60. Hoyler, T., C. S. Klose, A. Souabni, A. Turqueti-Neves, D. Pfeifer, E. L. Rawlins, D. Voehringer, M. Busslinger, and A. Diefenbach. 2012. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. *Immunity* 37: 634-648.

61. Klein Wolterink, R. G., N. Serafini, M. van Nimwegen, C. A. Vosshenrich, M. J. de Bruijn, D. Fonseca Pereira, H. Veiga Fernandes, R. W. Hendriks, and J. P. Di Santo. 2013. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells. *Proc. Natl. Acad. Sci. USA* 110: 10240-10245.

62. Serafini, N., R. G. Klein Wolterink, N. Satoh-Takayama, W. Xu, C. A. Vosshenrich, R. W. Hendriks, and J. P. Di Santo. 2014. Gata3 drives de- velopment of RORγt+ group 3 innate lymphoid cells. *J. Exp. Med.* 211: 199- 208.

63. Holmes, M. L., N. D. Huntington, R. P. Thong, J. Brady, Y. Hayakawa, C. E. Andoniou, P. Fleming, W. Shi, G. K. Smyth, M. A. Degli-Esposti, et al. 2014. Peripheral natural killer cell maturation depends on the transcription factor Aiolos. *EMBO J.* 33: 2721-2734.

64. Jenne, C. N., A. Enders, R. Rivera, S. R. Watson, A. J. Bankovich, J. P. Pereira, Y. Xu, C. M. Roots, J. N. Beilke, A. Banerjee, et al. 2009. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. *J. Exp. Med.* 206: 2469-2481.

65. Kallies, A., S. Carotta, N. D. Huntington, N. J. Bernard, D. M. Tarlinton, M. J. Smyth, and S. L. Nutt. 2011. A role for Blimp1 in the transcriptional network controlling natural killer cell maturation. *Blood* 117: 1869-1879.
66. Deng, Y., Y. Kerdiles, J. Chu, S. Yuan, Y. Wang, X. Chen, H. Mao, L. Zhang, J. Zhang, T. Hughes, et al. 2015. Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function. *Immunity* 42: 457-470.

67. Wang, K. S., D. A. Frank, and J. Ritz. 2000. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. *Blood* 95: 3183-3190.

68. Kim, S., K. Iizuka, H. S. Kang, A. Dokun, A. R. French, S. Greco, and W. M. Yokoyama. 2002. In vivo developmental stages in murine natural killer cell maturation. *Nat. Immunol.* 3: 523-528.

69. Yoshizawa, K., S. Nakajima, T. Notake, S. Miyagawa, S. Hida, and S. Taki. 2011. IL-15-high-responder developing NK cells bearing Ly49 receptors in IL-15<sup>-/-</sup> mice. *J. Immunol.* 187: 5162-5169.

70. Ramirez, K., K. J. Chandler, C. Spaulding, S. Zandi, M. Sigvardsson, B. J. Graves, and B. L. Kee. 2012. Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1. *Immunity* 36: 921-932.

71. Marusina, A. I., D. K. Kim, L. D. Lieto, F. Borrego, and J. E. Coligan. 2005. GATA-3 is an important transcription factor for regulating human NKG2A gene expression. *J. Immunol.* 174: 2152-2159.
<figure><img src="image_27.png" /></figure>

<figure><img src="image_28.png" /></figure>

<figure><img src="image_29.png" /></figure>

SUPPLEMENTAL FIGURE 1. Transcript levels of several transcription factors and surface expression of Ly49 receptors and molecules involved in cell adhesion in NK cells from *NKp46-Cre-Gata3fl/fl* mice and control littermates. (A) Total RNA was extracted from splenic NK cells and the expression of several transcription factors was quantified by quantitative real-time PCR. Graph depicts relative mRNA levels in NK cells from *Gata3fl/fl* (white bars) or *NKp46-Cre-Gata3fl/fl* (black bars) mice. (B and C) Flow cytometric analysis of several receptors on NK cells from *NKp46-Cre-Gata3fl/fl* and *Gata3fl/fl* mice comparing DN, CD27 SP, DP, and CD11b SP subsets. For (A), data are from one experiment representative of two independent experiments, with two replicates per group. For (B and C), data are from one experiment representative of two independent experiments, with three mice per group. Data represent mean + standard deviation.
*p* < 0.05; **p* < 0.01; ***p* < 0.001.
<figure><img src="image_30.png" /><figcaption>C</figcaption></figure>

<figure><img src="image_31.png" /><figcaption>E</figcaption></figure>

<figure><img src="image_32.png" /><figcaption>B</figcaption></figure>

<figure><img src="image_33.png" /><figcaption>D</figcaption></figure>

<figure><img src="image_34.png" /><figcaption>F</figcaption></figure>

<figure><img src="image_35.png" /></figure>

SUPPLEMENTAL FIGURE 2. IFN-γ production and CD25 expression in NK cells from *NKp46-Cre-Gata3<sup>fl/fl</sup>* mice upon MCMV infection. *NKp46-Cre-Gata3<sup>fl/fl</sup>* or *Gata3<sup>fl/fl</sup>* mice were either uninfected or given 5,000 PFU MCMV i.p. and sacrificed for the following analyses: NK cell subsets from naïve or MCMV-infected mice were stained for (A and B) IFN-γ production and (C and D) CD25 expression at day 1.5 post MCMV infection. (E and F) Representative plots of Ki-67 expression in different subsets of liver NK cells at day 2.5 post MCMV infection. Data are from one experiment representative of two independent experiments, with three mice per group. Data represent mean ± standard deviation. \*p < 0.05.
<figure><img src="image_36.png" /><figcaption>C</figcaption></figure>

<figure><img src="image_37.png" /><figcaption>E</figcaption></figure>

<figure><img src="image_38.png" /><figcaption>F</figcaption></figure>

<figure><img src="image_39.png" /><figcaption>G</figcaption></figure>

<figure><img src="image_40.png" /><figcaption>H</figcaption></figure>

<figure><img src="image_41.png" /><figcaption>B</figcaption></figure>

<figure><img src="image_42.png" /></figure>

IL-12

<figure><img src="image_43.png" /></figure>

IL-18

<figure><img src="image_44.png" /></figure>

IL-12/IL-18

<figure><img src="image_45.png" /></figure>

SUPPLEMENTAL FIGURE 3. CD27 SP and DP NK cells subsets show efficient upregulation of CD25 upon stimulation with IL-12 and IL-18, while NK cells from *NKp46-Cre-Gata3<sup>fl/fl</sup>* mice show enhanced proliferation upon stimulation with either IL-2 or IL-15. (A and B) CD25 expression on different subsets of NK cells following stimulation with IL-12 and/or IL-18 for 24 hours. (C and D) IL-18Rα expression on different subsets of NK cells. (E and F) BrdU incorporation in vitro upon culture with low doses of IL-2. (G and H) Histograms depict the proliferation of NK cells following 5 days of culture with the indicated concentrations of IL-15. For (B, F and H), data are from one experiment representative of two independent experiments, with triplicates per group. For (D), data are from one experiment representative of two independent experiments, with three mice per group. Data represent mean + standard deviation. \*p < 0.05; \*\*p < 0.01; \*\*\*p < 0.001.